Noninvasive imaging evaluation of tumor immune microenvironment to predict outcomes in gastric cancer
- 30 March 2020
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 31 (6), 760-768
- https://doi.org/10.1016/j.annonc.2020.03.295
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- ImmunoScore SignatureAnnals of Surgery, 2018
- Mismatch Repair Deficiency, Microsatellite Instability, and SurvivalJAMA Oncology, 2017
- Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric CancerJAMA Surgery, 2017
- Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRIBreast Cancer Research, 2017
- Interleukin-17–Producing Neutrophils Link Inflammatory Stimuli to Disease Progression by Promoting Angiogenesis in Gastric CancerClinical Cancer Research, 2017
- Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexityNature Reviews Drug Discovery, 2017
- Radiomics: Images Are More than Pictures, They Are DataRadiology, 2016
- The prognostic landscape of genes and infiltrating immune cells across human cancersNature Medicine, 2015
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trialThe Lancet Oncology, 2014
- Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil ChemotherapyClinical Cancer Research, 2008